SurgeryRSSQNCT07051941
Validation of a User Questionnaire to Assess Surgeon Satisfaction and Perspectives on Robotic Surgical Systems
An observational study of Surgery, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Trial summary
Robotic surgery represents a cornerstone for surgical treatment of different diseases. Since the Da Vinci patent expiry, several new robotic systems entered the market in the effort to spread to a greater extent the benefits of robotic surgery. Read more about this study
- Who is it for?
- Ages 30 to 70 years
- Conditions the study is for
- Surgery
- What is being tested?
- Validation of a satisfaction questionnaire for robotic surgeon
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 1 Jul 2025to 1 Dec 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 70 years
- All sexes
- Adult, Older adult
Study population: Participant surgeons will be recruited among scientific organization/communities focused on robotic surgery
Who may be able to join
- Board-certified surgeons
- At least 1 year of experience with robotic-assisted surgery
- Signed informed consent to participate
Who cannot join
- Participants not fitting inclusion criteria
- Unwilling to participate
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Validation of a User Questionnaire to Assess Surgeon Satisfaction and Perspectives on Robotic Surgical Systems (Robotic Surgeon Satisfaction Questionnaire - RSSQ)
Robotic surgery represents a cornerstone for surgical treatment of different diseases. Since the Da Vinci patent expiry, several new robotic systems entered the market in the effort to spread to a greater extent the benefits of robotic surgery. Even if clinical comparison between new systems and the Da Vinci platform are currently available, there is lack of reporting about subjective perception of surgeons approaching new platforms; personal feedback on fluency and precision, ergonomics, OR communication and other items are missing.The aim of the study is to validate a practical, reproducible, and comparable instrument that can be applied in both clinical research and in the evaluation processes of newly introduced surgical robotic platforms.
Read the detailed description
In recent years, the expansion of the robotic surgery landscape has been marked by the introduction of several new systems alongside the well-established Da Vinci platform. Emerging technologies such as Hugo™, Versius™, and Toumai™ offer distinct features in terms of ergonomics, system flexibility, user interface, and integration within the intraoperative workflow.
Initial comparison between new systems and the Da Vinci platform are currently available and include both clinical [1] and cost comparison [2,3]. However, there is a lack of reporting about subjective perception of surgeons approaching new platforms; personal feedback on fluency and precision, ergonomics, OR communication and other items are missing.
Some studies tried to address the issue [4-7]; however, to now, no instrument able to evaluate users' satisfaction on different robotic system is available.
Thus, there is a growing need for standardized tools capable of capturing the surgeon's subjective experience when using a specific robotic platform.
The present study aims to develop and validate a user satisfaction questionnaire for surgeons who operate with robotic systems, with the goal of assessing both qualitative and quantitative aspects related to perceived reliability and safety, movement fluency, ergonomic comfort, communication with staff, ease of setup (docking), and overall satisfaction.
In this evolving landscape, standardized tools are essential to assess surgeons' subjective perceptions regarding the use of specific robotic platforms. User satisfaction is a critical indicator for the adoption and effectiveness of new surgical technologies.
The aim of the study is to provide a practical, reproducible, and comparable instrument that can be applied in both clinical research and in the evaluation processes of newly introduced surgical robotic platforms.
STUDY OBJECTIVE
This study aims to validate a surgeon satisfaction questionnaire for those surgeons utilizing robotic surgical systems. The goal is to evaluate qualitative and quantitative aspects related to:
- Perceived reliability and safety
- Movement fluidity
- Ergonomics and physical comfort
- Communication with staff
- Ease of setup (docking)
- Overall satisfaction The questionnaire has been developed by two surgeons (MCS and BR) for the evaluation of a single robotic system and could be intended as "procedure-specific" or it could also be used to assess the overall and comprehensive performance of the platform (non-procedure specific).
The questionnaire does not represent itself a tool for the comparison of new robotic systems; however, its outcome measures are objective and could be used for the comparative evaluation of robotic systems. The questionnaire could be applied to surgeons of different disciplines (urology; general surgery; gynecology; etc).
METHODS Study Design This study follows a cross-sectional design. The primary endpoint is to validate a questionnaire to assess user satisfaction among expert surgeons utilizing various surgical robotic systems, including - but not limited to - the Da Vinci®, Hugo™ RAS, Versius®, and Toumai® platforms.
The Questionnaire has been developed from two Authors (MCS and BR) according to the following steps:
- Literature Review and Domain Identification A comprehensive literature review was conducted to identify key domains related to user satisfaction with robotic surgical systems. Major areas identified include:
- System reliability and precision
- Ease of setup and docking
- Instrument and console ergonomics
- System-team communication
- Intuitive control and usability
- Visual quality and haptics
- Workflow fluency
- Perceived safety and trust in technology
- Item Generation Based on these domains, an initial pool of items was generated; items were formulated as Likert-scale questions (5-point) and grouped into thematic sections. Both positive and negative phrasing was used to reduce response bias. An draft of the survey is reported as Supplementary Material.
The validation of the Questionnaire will be developed with a 2-step process.
- Test for Content Validity and Face Validity: a pilot test will be performed with 5-10 surgeons from FPG to ensure content and face validity, item comprehension, and usability.
- Validation from external users:
Participants
The validation study will include a cohort of expert robotic surgeons (n = ~50-100) who have performed at least 100 robotic procedures with one or more platforms (Da Vinci®, Hugo™, etc.). Inclusion criteria:
- Board-certified surgeons
- At least 1 year of experience with robotic-assisted surgery
- Informed consent to participate Participants will be recruited on a voluntary basis from the boards/members of international scientific societies (ERUS Scientific Working Group - European Robotic Urology Section; Agile Group; Society of Robotic Surgery); surgeons will be enrolled from high-volume surgical centers in Europe, North America, and Asia, South America, Africa.
Data Collection Surgeons will be invited to complete the questionnaire via a secure web-based platform (Survey Monkey). The on-line questionnaire will start with a brief explanation of the project and with the Informed Consent to be signed from the surgeon to participate in the study; if denied, the questionnaire will be automatically deleted. If the surgeon agrees to participates, the questionnaire will develop according to the attached Supplementary File. Demographic data (age, gender, years of robotic experience, surgical specialty, platform used) will also be collected.
Statistical analysis Reliability Analysis
- Internal consistency will be assessed using Cronbach's alpha for each domain. A threshold of α ≥ 0.70 will be considered acceptable.
- Item-total correlations and inter-item correlations will be examined. Construct Validity
- Exploratory Factor Analysis will be performed using principal component analysis with varimax rotation to identify the latent structure of the questionnaire.
- The Kaiser-Meyer-Olkin measure and Bartlett's test of sphericity will assess data suitability for factor analysis.
Test-Retest Reliability A subgroup of surgeons (n = 20) will be asked to complete the questionnaire twice, 1-2 weeks apart. Intraclass Correlation Coefficient (ICC) will be calculated to evaluate temporal stability.
- Conditions
- Surgery
- Being tested
- Validation of a satisfaction questionnaire for robotic surgeon
- Keywords
- robotic surgery, robotic system, precision, ergonomics, safety
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Validation of a satisfaction questionnaire for robotic surgeonOther
The primary endpoint is to validate a questionnaire to assess user satisfaction among expert surgeons utilizing various surgical robotic systems, including - but not limited to - the Da Vinci®, Hugo™ RAS, Versius®, and Toumai® platforms.
Based on these domains, an initial pool of items was generated; items were formulated as Likert-scale questions (5-point) and grouped into thematic sections.
The validation of the Questionnaire will be developed with a 2-step process.
- Test for Content Validity and Face Validity: a pilot test will be performed with 5-10 surgeons from FPG to ensure content and face validity, item comprehension, and usability.
- Validation from external users:
| Study group | Role | What they receive |
|---|---|---|
| Surgeon | The validation study will include a cohort of expert robotic surgeons (n = ~50-100) who have performed at least 100 robotic procedures with one or more platforms (Da Vinci®, Hugo™, etc.). Inclusion criteria:
* Board-certified surgeons
* At least 1 year of experience with robotic-assisted surgery
* Informed consent to participate Receives: Other: Validation of a satisfaction questionnaire for robotic surgeon |
What is being measured
The primary outcome is the main question the study is designed to answer.
Internal consistency.
Internal consistency: assessed using Cronbach's alpha for each domain. A threshold of α ≥ 0.70 will be considered acceptable.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jul 2025
- Study start1 Jul 2025 (estimated)
- Primary completion1 Oct 2025 (estimated)
- Study completion1 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SurgeryStudies of the same condition, open and under way.
- More trials run by Fondazione Policlinico Universitario Agostino Gemelli IRCCSThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Maria chiara Sighinolfi, Principal investigator, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07051941
- Sponsor's protocol ID
- 7809
- Acronym
- RSSQ
- Status last verified
- Jun 2025
- First submitted
- 26 Jun 2025
- Last updated
- 4 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 4 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validation of a User Questionnaire to Assess Surgeon Satisfaction and Perspectives on Robotic Surgical Systems (Robotic Surgeon Satisfaction Questionnaire - RSSQ)
- ClinicalTrials.gov ID
- NCT07051941
- Acronym / sponsor ID
- RSSQ / 7809
- Conditions
- Surgery
- Keywords
- robotic surgery, robotic system, precision, ergonomics, safety
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSUniversity, hospital or other
- Study start
- 1 Jul 2025 (estimated)
- Primary completion
- 1 Oct 2025 (estimated)
- Study completion
- 1 Dec 2025 (estimated)
- First posted
- 4 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Robotic surgery represents a cornerstone for surgical treatment of different diseases. Since the Da Vinci patent expiry, several new robotic systems entered the market in the effort to spread to a greater extent the benefits of robotic surgery. Even if clinical comparison between new systems and the Da Vinci platform are currently available, there is lack of reporting about subjective perception of surgeons approaching new platforms; personal feedback on fluency and precision, ergonomics, OR communication and other items are missing.The aim of the study is to validate a practical, reproducible, and comparable instrument that can be applied in both clinical research and in the evaluation processes of newly introduced surgical robotic platforms.
Detailed description
In recent years, the expansion of the robotic surgery landscape has been marked by the introduction of several new systems alongside the well-established Da Vinci platform. Emerging technologies such as Hugo™, Versius™, and Toumai™ offer distinct features in terms of ergonomics, system flexibility, user interface, and integration within the intraoperative workflow.
Initial comparison between new systems and the Da Vinci platform are currently available and include both clinical [1] and cost comparison [2,3]. However, there is a lack of reporting about subjective perception of surgeons approaching new platforms; personal feedback on fluency and precision, ergonomics, OR communication and other items are missing.
Some studies tried to address the issue [4-7]; however, to now, no instrument able to evaluate users' satisfaction on different robotic system is available.
Thus, there is a growing need for standardized tools capable of capturing the surgeon's subjective experience when using a specific robotic platform.
The present study aims to develop and validate a user satisfaction questionnaire for surgeons who operate with robotic systems, with the goal of assessing both qualitative and quantitative aspects related to perceived reliability and safety, movement fluency, ergonomic comfort, communication with staff, ease of setup (docking), and overall satisfaction.
In this evolving landscape, standardized tools are essential to assess surgeons' subjective perceptions regarding the use of specific robotic platforms. User satisfaction is a critical indicator for the adoption and effectiveness of new surgical technologies.
The aim of the study is to provide a practical, reproducible, and comparable instrument that can be applied in both clinical research and in the evaluation processes of newly introduced surgical robotic platforms.
STUDY OBJECTIVE
This study aims to validate a surgeon satisfaction questionnaire for those surgeons utilizing robotic surgical systems. The goal is to evaluate qualitative and quantitative aspects related to:
- Perceived reliability and safety
- Movement fluidity
- Ergonomics and physical comfort
- Communication with staff
- Ease of setup (docking)
- Overall satisfaction The questionnaire has been developed by two surgeons (MCS and BR) for the evaluation of a single robotic system and could be intended as "procedure-specific" or it could also be used to assess the overall and comprehensive performance of the platform (non-procedure specific).
The questionnaire does not represent itself a tool for the comparison of new robotic systems; however, its outcome measures are objective and could be used for the comparative evaluation of robotic systems. The questionnaire could be applied to surgeons of different disciplines (urology; general surgery; gynecology; etc).
METHODS Study Design This study follows a cross-sectional design. The primary endpoint is to validate a questionnaire to assess user satisfaction among expert surgeons utilizing various surgical robotic systems, including - but not limited to - the Da Vinci®, Hugo™ RAS, Versius®, and Toumai® platforms.
The Questionnaire has been developed from two Authors (MCS and BR) according to the following steps:
- Literature Review and Domain Identification A comprehensive literature review was conducted to identify key domains related to user satisfaction with robotic surgical systems. Major areas identified include:
- System reliability and precision
- Ease of setup and docking
- Instrument and console ergonomics
- System-team communication
- Intuitive control and usability
- Visual quality and haptics
- Workflow fluency
- Perceived safety and trust in technology
- Item Generation Based on these domains, an initial pool of items was generated; items were formulated as Likert-scale questions (5-point) and grouped into thematic sections. Both positive and negative phrasing was used to reduce response bias. An draft of the survey is reported as Supplementary Material.
The validation of the Questionnaire will be developed with a 2-step process.
- Test for Content Validity and Face Validity: a pilot test will be performed with 5-10 surgeons from FPG to ensure content and face validity, item comprehension, and usability.
- Validation from external users:
Participants
The validation study will include a cohort of expert robotic surgeons (n = ~50-100) who have performed at least 100 robotic procedures with one or more platforms (Da Vinci®, Hugo™, etc.). Inclusion criteria:
- Board-certified surgeons
- At least 1 year of experience with robotic-assisted surgery
- Informed consent to participate Participants will be recruited on a voluntary basis from the boards/members of international scientific societies (ERUS Scientific Working Group - European Robotic Urology Section; Agile Group; Society of Robotic Surgery); surgeons will be enrolled from high-volume surgical centers in Europe, North America, and Asia, South America, Africa.
Data Collection Surgeons will be invited to complete the questionnaire via a secure web-based platform (Survey Monkey). The on-line questionnaire will start with a brief explanation of the project and with the Informed Consent to be signed from the surgeon to participate in the study; if denied, the questionnaire will be automatically deleted. If the surgeon agrees to participates, the questionnaire will develop according to the attached Supplementary File. Demographic data (age, gender, years of robotic experience, surgical specialty, platform used) will also be collected.
Statistical analysis Reliability Analysis
- Internal consistency will be assessed using Cronbach's alpha for each domain. A threshold of α ≥ 0.70 will be considered acceptable.
- Item-total correlations and inter-item correlations will be examined. Construct Validity
- Exploratory Factor Analysis will be performed using principal component analysis with varimax rotation to identify the latent structure of the questionnaire.
- The Kaiser-Meyer-Olkin measure and Bartlett's test of sphericity will assess data suitability for factor analysis.
Test-Retest Reliability A subgroup of surgeons (n = 20) will be asked to complete the questionnaire twice, 1-2 weeks apart. Intraclass Correlation Coefficient (ICC) will be calculated to evaluate temporal stability.
Study design
- Observational model
- Other
- Time perspective
- Other
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Surgeon | – | Other: Validation of a satisfaction questionnaire for robotic surgeonThe validation study will include a cohort of expert robotic surgeons (n = ~50-100) who have performed at least 100 robotic procedures with one or more platforms (Da Vinci®, Hugo™, etc.). Inclusion criteria: * Board-certified surgeons * At least 1 year of experience with robotic-assisted surgery * Informed consent to participate |
Who may qualify
- Ages
- 30 to 70 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Participant surgeons will be recruited among scientific organization/communities focused on robotic surgery
Key inclusion criteria (3 listed)
- Board-certified surgeons
- At least 1 year of experience with robotic-assisted surgery
- Signed informed consent to participate
Key exclusion criteria (2 listed)
- Participants not fitting inclusion criteria
- Unwilling to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Validation of a satisfaction questionnaire for robotic surgeonThe primary endpoint is to validate a questionnaire to assess user satisfaction among expert surgeons utilizing various surgical robotic systems, including - but not limited to - the Da Vinci®, Hugo™ RAS, Versius®, and Toumai® platforms. Based on these domains, an initial pool of items was generated; items were formulated as Likert-scale questions (5-point) and grouped into thematic sections. The validation of the Questionnaire will be developed with a 2-step process. 1. Test for Content Validity and Face Validity: a pilot test will be performed with 5-10 surgeons from FPG to ensure content and face validity, item comprehension, and usability. 2. Validation from external users: | Other | Surgeon |
Primary outcome
Internal consistency.
Time frame: 6 months
Internal consistency: assessed using Cronbach's alpha for each domain. A threshold of α ≥ 0.70 will be considered acceptable.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jul 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Surgery
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider
Spinal (Fusion) Surgery, Total Intravenous Anesthesia
RecruitingPhase 1
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Renal Failure Congenital, Congenital Renal Anomaly Nos
RecruitingPhase 2
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
RecruitingPhase 2/3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Maria chiara Sighinolfi principal investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Questions about this trial
What is this clinical trial studying?
An observational study of Surgery, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Maria Chiara Sighinolfi (0039 3921329216, mariachiara.sighinolfi@policlinicogemelli.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Internal consistency. (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jul 2025.